Dietrich A. Stephan serves as Executive at NeuBase Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Dietrich A. Stephan has executed 12 insider transactions totaling $120.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 2, 2023 involved exercising options for 93,234 shares valued at $1.9K.
Dietrich A. Stephan currently holds 93,234 shares of NeuBase Therapeutics, Inc. (NBSE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dietrich A. Stephan has been a net buyer of NBSE stock. They have purchased $120.0K and sold $0 worth of shares.
Dietrich A. Stephan's most recent insider trade was on Aug 2, 2023, when they sold 93,234 shares at $0.02 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 13, 2023 | NBSE | $0 | Option Exercise | 655,000 | $N/A | Discretionary |
| Sep 28, 2022 | NBSE | $0 | Option Exercise | 750,000 | $N/A | Discretionary |
| Dec 31, 2021 | NBSE | $0 | Option Exercise | 42,250 | $N/A | Discretionary |
| Apr 26, 2021 | NBSE | $60.0K | Purchase | 12,000 | $5.00 | Discretionary |
| Dec 1, 2020 | NBSE | $0 | Gift | 1,273,820 | $N/A | Discretionary |
| Dec 1, 2020 | NBSE | $0 | Gift | 1,273,819 | $N/A | Discretionary |
| Nov 30, 2020 | NBSE | $0 | Gift | 1,273,819 | $N/A | Discretionary |
| Nov 23, 2020 | NBSE | $0 | Gift | 2,547,639 | $N/A | Discretionary |
| Apr 30, 2020 | NBSE | $60.0K | Purchase | 10,000 | $6.00 | Discretionary |
| Jul 12, 2019 | NBSE | $0 | Award | 2,547,639 | $N/A | Discretionary |